Before the pandemic hit, the Yale Center for Clinical Investigation had presciently prepared for it.
- June 04, 2020
The Yale Department of Psychiatry continues to offer virtual “Stress and Resilience Town Halls” over Zoom that are open to all faculty, residents, and staff at Yale School of Medicine and Yale New Haven Health. Virtual meetings will run for up to an hour. Individuals can attend as frequently as they like.
- May 21, 2020Source: Yale Medicine
Wherever constant stress lives, so too does its more agitated and debilitating cousin: anxiety. About 31% of Americans will experience an anxiety disorder at some point in their lives. What’s more, anxiety often goes hand-in-hand with depression.
- April 30, 2020
The promise of parent-child education programs on improving parenting practices and reducing stress in conflict-exposed families
Yale led research study shows that early childhood parenting education programs have a positive impact on disciplinary practices and parenting stress for families that experience humanitarian crises such as exposure to conflict, displacement, and economic marginalization.
- April 01, 2020
Dr. Christopher Pittenger, director of the Yale OCD Research Clinic, offers clinical insights at a time of high anxiety.
- March 19, 2020
Beginning Friday, March 20, the Department of Psychiatry will offer virtual “Stress and Resilience town halls” over Zoom that are open to all faculty, residents, students, and staff at Yale School of Medicine and Yale New Haven Health. Virtual meetings will take place twice daily and run for up to an hour. Individuals can attend as frequently as they like.
- January 14, 2020
Yale School of Medicine and FDA’s Office of Minority Health and Health Equity Diversity Day: "Patient Centered Approach to Care and Research" on Feb. 28
The Innovation and Diversity Summit will focus on raising awareness about the need for minorities and subpopulation participation in clinical trials; patient-centered approaches to care and research; and the role of technology in both areas.
- December 18, 2019Source: Yale Medicine
Yale addiction specialists believe the primary care system can play a key role in preventing another medication epidemic. David A. Fiellin, MD, worries that otherwise, the trajectory of benzodiazepine prescriptions might lead to a situation that resembles the opioid crisis.
- October 03, 2019Source: Antidepressants Are Safe: Final Word?
Results from a large umbrella review of 45 meta-analyses that included > 1000 observational studies show that “there is no convincing evidence of a link between antidepressant use and adverse health outcomes.” According to Medscape: “Some experts urge caution in interpreting the results. "While the methods of this review are sound … and the discussion of these meta-analyses is balanced, an important limitation of meta-analysis and umbrella reviews is the risk of reductionism," write Michael Bloch, MD, Victor Avila-Quintero, MD, and Jose Flores, MD, PhD, all from Yale University School of Medicine. The editorialists say determining the risks of medication exposure during pregnancy is "important and of great concern" to families, physicians, and children. "Systematic reviews, meta-analyses, and the umbrella reviews will report more precise estimates of associations that are subject to confounding and bias, leading to false accuracy and certainty," they conclude.
- September 11, 2019Source: PBS
Ketamine, originally used as an anesthesia medicine and later abused as a "club drug," may be one of the most important developments for treating depression. Dr. John H. Krystal, M.D., chair of the Yale School of Medicine Department of Psychiatry and professor of translational research, psychiatry and neuroscience, discusses his groundbreaking study on the subject.